Background Currently, two major magnetic resonance (MR) vendors provide commercial 7‑T
scanners that are approved by the Food and Drug Administration (FDA) for clinical …

Magnetic resonance imaging (MRI) is essential for the early diagnosis of multiple sclerosis
(MS), for investigating the disease pathophysiology, and for discriminating MS from other …

In recent years, ultra-high field MRI (7 T and above) has received more interest for clinical
imaging. Indeed, a number of studies have shown the benefits from the application of this …

BACKGROUND AND PURPOSE: Higher magnetic field strengths and continuous
improvement of high-resolution imaging in multiple sclerosis (MS) are expected to provide …

Purpose Magnetic resonance imaging (MRI) is one of the most important methods for the
diagnosis and therapy monitoring of various diseases. Today, magnets up to 3 T are …

Introduction: Magnetic resonance imaging (MRI) is of paramount importance for the early
diagnosis of multiple sclerosis (MS) and MRI findings are part of the MS diagnostic criteria …

The overall goal of this article is to demonstrate a state-of-the-art ultrahigh field (UHF)
magnetic resonance (MR) protocol of the brain at 7.0 Tesla in multiple sclerosis (MS) …

The long-standing relationship between ultra-high-field (7 T) MRI and multiple sclerosis
(MS) has brought new insights to our understanding of lesion evolution and its associated …

Following the approval of the US Food and Drug Administration (FDA), high field magnetic
resonance imaging (MRI) has been increasingly incorporated into the clinical setting …

The first publications about in vivo application of ultra-high field MRI in multiple sclerosis
(MS) appeared in 2008. From then on, the number of studies performed at 7 Tesla (T) has …